Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Press Release

FOR IMMEDIATE RELEASE ON April 02, 2003

Cerebral Palsy Symptoms Improve with Botulinum Toxin

Embargoed for meeting release until 11:00 am HT, Wed., April 2, 2003

Honolulu, Hawaii -

Children with cerebral palsy show long-term improvement through treatment with botulinum toxin, according to research presented during the American Academy of Neurology Annual Meeting in Honolulu, March 29-April 5, 2003. Children treated with the drug had improvements ranging from making voluntary movements for the first time to improved stance and walking, according to the study’s lead author, neurologist Marc P. DiFazio, MD, of Walter Reed Army Medical Center in Washington, DC. "It''''''''s very exciting to see the progress these kids can make," DiFazio said. "Some of them are able to do more for themselves, like feeding themselves or turning on a faucet. Some were able to hold a pen and write for the first time, or use a computer touch screen to communicate. These may not seem like big changes, but they can be life-changing for these kids and their families." The study involved 250 children, ages one to 16, who received botulinum toxin to treat their cerebral palsy. Of those, 206 children had repeated treatments and 148 were followed for longer than one year, for an average of more than two years. A total of 86 percent of the children had notable improvement in their symptoms of muscle spasticity after the injections, as measured by videotape analysis, physician evaluation, spasticity rating scales, as well as the response of the family. Of those who continued treatment, 92 percent continued their favorable response to the drug longer than one to two years. Of those who were followed for more than two years, more than 80 percent continued to show improvement over their initial symptoms before beginning treatment, and those results often lasted longer than four months after an injection, DiFazio said. "These results confirm that botulinum toxin in appropriate dosing is safe and effective for long-term use for children with cerebral palsy," he said. Side effects from the drug were mild and uncommon, DiFazio said. Five children experienced temporary side effects -- four had a flu-like reaction and one had mild weakness in the legs. The researchers also found that no children developed resistance to the drug after repeated use. "It''''''''s great news for families of children with cerebral palsy that long-term use of botulinum toxin is safe," DiFazio said. "In the doses that we used, it had minimal adverse side effects and did not appear to lead to significant immune system resistance."

Brain & Life logo

GET A DOSE OF BRAIN HEALTH

Dive into a wealth of information by visiting Brain & Life®, where you can explore the freshest updates, tips, and neurologist expert perspectives on brain disease and preventive brain health.

DISCOVER MORE


Subscribe to our email newsletter

The American Academy of Neurology is the leading voice in brain health. As the world’s largest association of neurologists and neuroscience professionals with more than 44,000 members, the AAN provides access to the latest news, science and research affecting neurology for patients, caregivers, physicians and professionals alike. The AAN’s mission is to enhance member career fulfillment and promote brain health for all. A neurologist is a doctor who specializes in the diagnosis, care and treatment of brain, spinal cord and nervous system diseases such as Alzheimer's disease, stroke, concussion, epilepsy, Parkinson's disease, multiple sclerosis, headache and migraine.

Explore the latest in neurological disease and brain health, from the minds at the AAN at AAN.com or find us on Facebook, X, LinkedIn, Instagram and YouTube.

Editor's Notes: Dr. DiFazio will present the research at the AAN’s 55th Annual Meeting in Honolulu during a poster presentation on Thurs., April 3 at 5:30 p.m. in Kamehameha I and II at the Hawaii Convention Center (HCC). He will be available to answer media questions during a briefing on Wed., April 2 at 11:00 a.m. in the AAN Press Room, Room 327 of the HCC. All listed times are for Hawaiian-Aleutian Standard Time (HT).

For More Information*

Email media@aan.com

*While content of the American Academy of Neurology (AAN) press releases is developed by the AAN along with research authors and Neurology® editors, we are unable to provide medical advice to individuals. Please contact your health care provider for questions specific to your individual health history or care. For more resources, visit the AAN's patient and caregiver website, Brain & Life®.